OP RDE projects
Project title: UOCHB MSCA Mobility IV
Registration number: CZ.02.2.69/0.0/0.0/20_079/0017783
Brief description: The aim of the project is the establishment and the realization of international research cooperation by means of supporting the participation of a researcher in the fellowship at renowned research institution abroad. This project is focused on the researchers that did not succeed in H2020 MSCA IF 2019 call. The mutual exchange of experience, good research practice, enhancement of research staff knowledge, abilities, and skills as well as networking with research institutions across the world will ensure appropriate conditions for further development of the excellent research at the IOCB.
Realization schedule: 1. 10. 2020–30. 4. 2023
Principal investigator: Ing. Iva Pichova, CSc.
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
Project title: UOCHB Mobility II
Registration number: CZ.02.2.69/0.0/0.0/18_053/0016940
Brief description: The aim of the project is the establishment and the realization of the international cooperation by means of creating attractive research job positions for prospective candidates from abroad and by means of supporting the participation of current research and administrative staff in the internships at renowned research institutions abroad. Mutual exchange of experience, good research practice, enhancement of research staff knowledge, abilities, and skills will ensure the appropriate conditions for further development of the excellent research at the IOCB.
Realization schedule: 1. 4. 2020–30. 6. 2023
Principal investigator: Ing. Iva Pichova, CSc.
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
Project title: UOCHB MSCA Mobility III
Registration number: CZ.02.2.69/0.0/0.0/19_074/0016322
Brief description: The project aims to support a top researcher in reintegration activities within her home institution – the IOCB. The inclusion and creation of conditions for keeping excellent researchers in the European research environment and particularly in the organization of the beneficiary, contribute to the further development of excellence of both the researcher and the research performed at the IOCB. At the same time, there are benefits in the form of support for international cooperation through the researcher's links to a previous workplace abroad.
Realization schedule: 1. 4. 2020–30. 4. 2022
Principal investigator: Ing. Iva Pichova, CSc.
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
Project title: UOCHB MSCA Mobility II
Registration number: CZ.02.2.69/0.0/0.0/18_070/0010562
Brief description: The aim of the project is the establishment and the realization of international research cooperation by means of supporting the participation of research staff in the internships at renowned research institutions abroad. This project is focused on the researchers that did not succeed in H2020 MSCA IF 2017 call. The mutual exchange of experience, good research practice, the enhancement of research staff knowledge, abilities, and skills as well as networking with research institutions across the world will ensure appropriate conditions for further development of the excellent research at the IOCB.
Realization schedule: 1. 12. 2018–31. 7. 2021
Principal investigator: Ing. Iva Pichová, CSc.
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
Project title: Carbon allotropes with rationalized nanointerfaces and nanolinks for environmental and biomedical applications
Acronym: CARAT
Registration number: CZ.02.1.01/0.0/0.0/16_026/0008382
Brief description: The main motivation for the proposed project CARAT is a radical change in the modus operandi of interdisciplinary research in a highly actual research area focused on carbon nanomaterials. The project formulates a completely new strategy of the material design, with the ultimate aim of rationalizing communication channels (interfaces and nanolinks) to the environment in accordance with the nature of the chemical bond of the respective carbon allotrope. At the same time, the project targets the establishment of an expert team with a deep engagement in all relevant sectors of the academic and application interest. Based on previous successful cooperation at the national and international levels, the team members are able to speak the same language, so maximize the profit from the shared expertise and know-how. Internationally, an important outcome of the project is the establishment of the Joint Laboratory of Detonation Synthesis, where groundbreaking experiments will be conducted in the worldwide unique facility by a team of experts in all fields linked. In this context, it is expected that the Czech Republic will establish itself as a world power in the preparation of detonation nanodiamond with precisely defined parameters and hybrid materials based on graphenoids and/or nanodiamond for biomedicine, energy storage, and environmental applications.
Realization schedule: 1. 10. 2018–31. 12. 2022
Principal investigator: Mgr. Petr Cígler, Ph.D.
Beneficiary: J. Heyrovský Institute of Physical Chemistry of the CAS
Partners with a financial contribution:
- TESLA BLATNÁ
- OZM Research
- University of West Bohemia
- Charles University
- J. Heyrovský Institute of Physical Chemistry of the CAS
- Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
Project title: UOCHB MSCA Mobility
Registration number: CZ.02.2.69/0.0/0.0/17_050/0008490
Brief description: The aim of the project is the establishment and the realization of international research cooperation by means of supporting the participation of research staff in the internships at renowned research institutions abroad. This project is focused on the researchers that did not succeed in H2020 MSCA IF 2016 call. The mutual exchange of experience, good research practice, the enhancement of research staff knowledge, abilities, and skills as well as networking with research institutions across the world will ensure appropriate conditions for further development of the excellent research at the IOCB.
Realization schedule: 1. 3. 2018–31. 12. 2020
Principal investigator: Ing. Iva Pichová, CSc.
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
Project title: UOCHB Mobility
Registration number: CZ.02.2.69/0.0/0.0/16_027/0008477
Brief description: The aim of the project is the establishment and the realization of international research cooperation by means of creating attractive research job positions for prospective candidates from abroad and by means of supporting the participation of current research staff in the internships at renowned research institutions abroad. Mutual exchange of experience, good research practice, enhancement of research staff knowledge, abilities, and skills will ensure the appropriate conditions for further development of the excellent research at the IOCB.
Realization schedule: 22. 1. 2018–31. 3. 2021
Principal investigator: Ing. Iva Pichová, CSc.
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
Project title: PharmaBrain
Registration number: CZ.02.1.01/0.0/0.0/16_025/0007444
Brief description: The project is aimed at the research of the glutamatergic neurotransmitter system that controls a wide range of brain processes. This system also takes part in normal brain development, while the dysfunction of this system plays a key role in many neuropsychiatric diseases. The project is focused on its role in clinical practice as well as in experimental models. The research in this area has a long tradition in all participating institutions and also a high reputation among professionals worldwide.
Realization schedule: 1. 1. 2018–31. 12. 2022
Principal investigator: RNDr. Eva Kudová, Ph.D.
Beneficiary: National Institute of Mental Health Czech Republic (NÚDZ)
Partners of the project with a financial contribution:
- Institute of Physiology CAS (IPHYS)
- Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)
- University of Hradec Králové (UHK)
- 3rd Faculty of Medicine, Charles University
Project title: Chemical biology for drugging undruggable targets
Acronym: ChemBioDrug
Registration number: CZ.02.1.01/0.0/0.0/16_019/0000729
Brief description: The objective of a research agenda conceived in this way is the development of new potential therapeutics of cancers, viral diseases, and metabolic disorders on the principle of specific inhibition of so-called "undruggable" interactions of biomacromolecules, on which classical medicinal chemistry cannot reach. The research will be focused on three key types of biomolecular interactions: protein-protein; protein-membrane and protein-DNA or protein-RNA. With the use of a multidisciplinary approach combining the structurally- and molecularly biological characterization of the target biomacromolecules and their interactions, bioinformatics, and molecular modelling, design, and chemical synthesis of a series of potential inhibitors (including libraries of sequences of modified peptides and oligonucleotides), detailed testing of the inhibition of targeted biomolecular interactions, or in vitro selection methods of their identification from the libraries of sequences, and study of the cytostatic and antiviral activities or physiological effect of the tested substances, substances with the highest activity and lowest toxicity will be selected for further preclinical studies.
Within the project, research teams will be particularly enriched with newly acquired local and foreign talented doctoral candidates, post-docs, and junior researchers. The project will ensure the development of the existing infrastructure mainly in the area of theoretical calculations and modelling, experimental studies of protein interactions, automatic testing of substances, microscopy, sequencing RNA, DNA, and in the area of chromatographic separation. Project activities will support the international research cooperation with world-recognized research institutions: Catholic University in Leuven, Johns Hopkins University, and the pharmaceutical company Gilead Sciences, Inc.
Realization schedule: 1. 1. 2018–31. 12. 2022
Principal investigator: Prof. Ing. Michal Hocek, CSc. DSc.
Beneficiary: Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague)